NeuExcell Therapeutics

neuexcell.com
401 N Broad St
Philadelphia, PA 19108

Company Info

Year Established
2016

Contacts

Jian Sheng, MD, PhD
Co-Founder & CEO

Company Description

NeuExcell's ATN ASTROCYTES TO NEURONSTM platform uses gene therapy to deliver specific transcription factors to glial cells in the brain, which converts these cells into functional and fully integrated neurons.

Transfection Has Never Been So Easy With Avalanche® Transfection Reagents for Cancer Cells, Primary Cells, And Other Difficult-To-Transfect Cells.Primary Cells, And Other Difficult-To-Transfect Cells.